1-3 of 3
Jonathan Fish
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia

Brief Report
David T. Teachey, Cecilia Sheen, Junior Hall, Theresa Ryan, Valerie I. Brown, Jonathan Fish, Gregor S. D. Reid, Alix E. Seif, Robin Norris, Yueh J. Chang, Martin Carroll, Stephan A. Grupp
Journal: Blood
Blood (2008) 112 (5): 2020–2023.
https://doi.org/10.1182/blood-2008-02-137141
Published: 2008
Includes: Supplemental data
Journal Articles

PI3-Kinase Inhibition Decreases the Proliferation of ALL Cells, Potentiates mTOR Inhibition, and Abrogates Growth Factor-Mediated Reversal of mTOR Inhibition.

Jonathan Fish, MD, Jessica Hulitt, Marlo Bruno, Stephan A. Grupp, MD, PhD, Valerie I. Brown, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 1383.
https://doi.org/10.1182/blood.V108.11.1383.1383
Published: 2006
Journal Articles

Chimeric Immunoreceptor (T-Body) Targeting of Acute B-Cell Lymphoblastic Leukemia (B-ALL) through Lentivirus Engineering of Primary Human T Cells.

Michael C. Milone, MD, PhD, Jonathan Fish, MD, Carmine Carpenito, PhD, Mehdi Lakal, BS, Ella Ofori, BS, Gwenn Danet-Desnoyers, PhD, James L. Riley, PhD, Stephan A. Grupp, MD, PhD, Carl H. June, MD
Journal: Blood
Blood (2006) 108 (11): 3267.
https://doi.org/10.1182/blood.V108.11.3267.3267
Published: 2006